RaiseTrack

This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Avery Therapeutics Form D (2026)

Avery Therapeutics reported $8,468,859 raised in an SEC Form D filed on 2026-09-21.

Company
Avery Therapeutics
Round type
Form D
Date
2026-09-21
Amount
$8.47M
Industry
Biotechnology
Location
Arizona

Summary

The SEC Form D for Avery Therapeutics, filed on 2026-09-21, reports $8,468,859 raised. It was listed in the Raise Track Update of 2026-09-24. Filing: https://www.sec.gov/Archives/edgar/data/1708135/000170813526000003/0001708135-26-000003-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/1708135/000170813526000003/0001708135-26-000003-index.htm
    Type: sec filing. Accessed 2026-10-12.
    SEC Form D filed 2026-09-21 by Avery Therapeutics, Inc. Reports $8,468,859 of securities sold. It does not name investors or a round type.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-09-24/
    Type: other verified public source. Accessed 2026-10-12.
    Raise Track Update for 2026-09-24, Section 3 (SEC Form D filings). Lists Avery Therapeutics, state ARIZONA, industry Biotechnology, amount raised 8468859.